Impact of Home Confinement During the COVID‐19 Pandemic on Medication Use and Disease Activity in Spondyloarthritis Patients
- 17 June 2020
- journal article
- letter
- Published by Wiley in Arthritis & Rheumatology
- Vol. 72 (10), 1771-1772
- https://doi.org/10.1002/art.41397
Abstract
Home confinement, imposed as part of the social distancing measures in the fight against the coronavirus disease 2019 (COVID‐19), poses several problems for patients with spondyloarthritis (SpA), including the lack of physical activity, psychological factors, and the confusion related to the prescriptions of NSAIDs. We investigated the impact of confinement on the medication intake and disease activity in SpA patients in a questionnaire‐based survey.This publication has 9 references indexed in Scilit:
- Predicting response to anti-TNFα therapy among patients with axial spondyloarthritis (axSpA): results from BSRBR-ASRheumatology, 2020
- American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 1Arthritis & Rheumatology, 2020
- Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapiesAnnals Of The Rheumatic Diseases, 2020
- COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?ecancermedicalscience, 2020
- 2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial SpondyloarthritisArthritis & Rheumatology, 2019
- Anti-TNF Therapy in Spondyloarthritis and Related Diseases, Impact on the Immune System and Prediction of Treatment ResponsesFrontiers in Immunology, 2019
- 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritisAnnals Of The Rheumatic Diseases, 2017
- Risk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysisExpert Opinion on Drug Safety, 2016
- Efficacy of High Intensity Exercise on Disease Activity and Cardiovascular Risk in Active Axial Spondyloarthritis: A Randomized Controlled Pilot StudyPLOS ONE, 2014